Total Payments
$86,139
2024 Payments
$75,085
Companies
14
Transactions
40
Medicare Patients
8,331
Medicare Billing
$598,324
Payment Breakdown by Category
Other$78,700 (91.4%)
Consulting$4,895 (5.7%)
Food & Beverage$2,529 (2.9%)
Education$15.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $75,000 | 1 | 87.1% |
| Consulting Fee | $4,895 | 2 | 5.7% |
| Food and Beverage | $2,529 | 34 | 2.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 2.9% |
| Honoraria | $1,200 | 1 | 1.4% |
| Education | $15.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Research LLC | $75,000 | 1 | $0 (2024) |
| Allergan, Inc. | $8,145 | 15 | $0 (2020) |
| Alimera Sciences, Inc. | $1,298 | 2 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $573.60 | 5 | $0 (2023) |
| Dutch Ophthalmic, USA | $302.53 | 2 | $0 (2019) |
| Alcon Laboratories Inc | $182.22 | 5 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $163.87 | 2 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $127.42 | 2 | $0 (2019) |
| Genentech USA, Inc. | $120.24 | 1 | $0 (2018) |
| Genentech, Inc. | $115.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,085 | 4 | Alcon Research LLC ($75,000) |
| 2023 | $129.82 | 2 | Regeneron Healthcare Solutions, Inc. ($104.84) |
| 2022 | $1,200 | 1 | Alimera Sciences, Inc. ($1,200) |
| 2021 | $113.05 | 1 | Regeneron Healthcare Solutions, Inc. ($113.05) |
| 2020 | $49.17 | 2 | Allergan, Inc. ($49.17) |
| 2019 | $5,455 | 7 | Allergan Inc. ($4,895) |
| 2018 | $1,075 | 13 | Allergan Inc. ($579.23) |
| 2017 | $3,031 | 10 | Allergan Inc. ($2,622) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Alcon Research LLC | — | Grant | Cash or cash equivalent | $75,000.00 | General |
| 07/15/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: EYE CARE | ||||||
| 10/20/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.98 | General |
| 02/23/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $104.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Honoraria | Cash or cash equivalent | $1,200.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/26/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $113.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: RETINA | ||||||
| 05/15/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: RETINA | ||||||
| 09/18/2019 | Allergan Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $2,225.00 | General |
| Category: RETINA | ||||||
| 06/12/2019 | Allergan Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $2,670.00 | General |
| Category: RETINA | ||||||
| 05/30/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $119.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2019 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $173.33 | General |
| Category: Ophthalmology | ||||||
| 05/20/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $140.12 | General |
| 04/29/2019 | Carl Zeiss Meditec, Inc. | CIRRUS HD-OCT (Device), PLEX Elite 9000, Clarus 700 | Food and Beverage | In-kind items and services | $112.42 | General |
| Category: Optical Tomographer | ||||||
| 04/29/2019 | Carl Zeiss Meditec, Inc. | PLEX Elite 9000 (Device) | Education | In-kind items and services | $15.00 | General |
| Category: Optical Tomographer | ||||||
| 12/04/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $80.13 | General |
| Category: RETINA | ||||||
| 12/04/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $43.48 | General |
| Category: RETINA | ||||||
| 10/28/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $135.50 | General |
| Category: RETINA | ||||||
| 09/28/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $120.24 | General |
| Category: Ophthalmology | ||||||
| 07/21/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $54.99 | General |
| Category: RETINA | ||||||
| 07/03/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: RETINA | ||||||
| 06/27/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $132.60 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 2,292 | 3,993 | $1.3M | $175,851 |
| 2022 | 7 | 2,150 | 3,918 | $1.1M | $162,952 |
| 2021 | 9 | 2,066 | 3,463 | $914,161 | $147,426 |
| 2020 | 10 | 1,823 | 2,999 | $693,347 | $112,096 |
Total Patients
8,331
Total Services
14,373
Medicare Billing
$598,324
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 493 | 932 | $400,760 | $71,335 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 224 | 395 | $170,007 | $29,894 | 17.6% |
| 92134 | Imaging of retina | Office | 2023 | 528 | 1,007 | $125,875 | $20,625 | 16.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 79 | 224 | $261,812 | $18,159 | 6.9% |
| 67028 | Injection of drug into eye | Facility | 2023 | 47 | 117 | $136,570 | $9,438 | 6.9% |
| 92134 | Imaging of retina | Facility | 2023 | 244 | 459 | $57,375 | $9,249 | 16.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 397 | 539 | $35,574 | $6,446 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $31,507 | $5,085 | 16.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Facility | 2023 | 177 | 217 | $14,322 | $2,561 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $15,459 | $2,300 | 14.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 14 | 14 | $2,716 | $467.34 | 17.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 15 | 15 | $1,530 | $292.20 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 431 | 868 | $373,397 | $64,472 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 226 | 392 | $168,560 | $29,469 | 17.5% |
| 92134 | Imaging of retina | Office | 2022 | 478 | 990 | $123,750 | $19,652 | 15.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 59 | 207 | $182,925 | $15,831 | 8.7% |
| 92134 | Imaging of retina | Facility | 2022 | 243 | 445 | $55,625 | $8,951 | 16.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 375 | 570 | $37,620 | $6,523 | 17.3% |
| 67028 | Injection of drug into eye | Facility | 2022 | 33 | 75 | $69,105 | $5,982 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $35,807 | $5,932 | 16.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Facility | 2022 | 189 | 254 | $16,764 | $2,896 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 24 | 24 | $14,088 | $2,464 | 17.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 16 | 16 | $3,104 | $545.22 | 17.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 15 | 16 | $1,632 | $234.56 | 14.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 339 | 608 | $233,600 | $50,331 | 21.5% |
About Andrew Browne, M.D., PH.D
Andrew Browne, M.D., PH.D is a Ophthalmology healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1154615383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrew Browne, M.D., PH.D has received a total of $86,139 in payments from pharmaceutical and medical device companies, with $75,085 received in 2024. These payments were reported across 40 transactions from 14 companies. The most common payment nature is "Grant" ($75,000).
As a Medicare-enrolled provider, Browne has provided services to 8,331 Medicare beneficiaries, totaling 14,373 services with total Medicare billing of $598,324. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Irvine, CA
- Active Since 06/06/2011
- Last Updated 02/06/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1154615383
Products in Payments
- OZURDEX (Drug) $5,668
- BOTOX (Biological) $2,500
- ILUVIEN (Drug) $1,200
- EYLEA (Biological) $374.25
- EVA Ophthalmic Surgical System (Device) $302.53
- EYLEA AFLIBERCEPT INJECTION (Biological) $236.18
- Lucentis (Biological) $236.14
- Constellation (Device) $161.23
- CIRRUS HD-OCT (Device) $112.42
- Iluvien (Drug) $97.50
- OXERVATE (Drug) $25.02
- AcrySof (Device) $20.99
- PLEX Elite 9000 (Device) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Irvine
Baruch Kuppermann, Md, MD
Ophthalmology — Payments: $996,400
Ophthalmology $996,400
Dr. Marjan Farid, Md, MD
Ophthalmology — Payments: $673,334
Ophthalmology $673,334
Dr. Rhett Schiffman, Md, MD
Ophthalmology — Payments: $461,992
Ophthalmology $461,992
Dr. Mitul Mehta, Md, MD
Ophthalmology — Payments: $221,612
Ophthalmology $221,612
Dr. Sameh Mosaed, Md, MD
Ophthalmology — Payments: $85,352
Ophthalmology $85,352
Dr. Vivek Patel, M.d, M.D
Ophthalmology — Payments: $75,541
Ophthalmology $75,541